Pharmaust Limited

ASX:PAA ISIN:AU000000PAA1

PharmAust LtdPharmAust specialises in the relaunch of existing marketed products for oncology applications making the whole development, regulatory and commercialisation process much faster. In addition, PharmAust's other wholly owned subsidiary, Epichem Pty Ltd generates sales of around $1.7M per annum from contract sales to the pharmaceutical industry of synthetic drugs.

 
    
          

View in Other Languages

News

PharmAust Limited (ASX:PAA) Clinical Trial in Dogs for Treatment of Canine Cancers

🕔5/2/2015 10:11:35 AM 5716

PharmAust Limited (ASX:PAA) is pleased to announce that further to its approval from the Department of Primary Industries to amend the current canine trial protocol for the treatment of cancer in dogs, the first dog treated under the new protocol has demonstrated approximately a 40% reduction in tumour marker p70S6K after only three days of treatment.

Read Full Article

ADX Energy Limited (ASX:ADX) Buys Back Further 10% Interest in Lambouka

🕔9/9/2011 2:16:00 PM 5764

ADX Energy Ltd (ASX:ADX) is pleased to announce a Sale and Purchase Agreement has been executed to buy back a further 10% interest in the Lambouka Prospect Area in the Kerkouane Permit from PharmAust Limited (ASX:PAA) and to cancel the option of PAA to purchase an interest in that part of the Lambouka prospect that extends into Italian waters.

Read Full Article

Australian Market Report of February 10, 2011: Calzada (ASX:CZD) Announce Positive Results In Human Stem Cell Study For Bone Growth

🕔2/10/2011 1:30:00 PM 13567

Australian Market Report of February 10, 2011 includes: Calzada (ASX:CZD) announced positive results in human stem cell study for bone growth; PharmAust Limited (ASX:PAA) is to acquire a European high grade precious and base metal project; Northern Star Resources (ASX:NST) announced strong gold production results in Western Australia; Latin Resources Limited (ASX:LRS) is to acquire 14,068 hectares of world class Iron and Heavy Mineral Sands tenements in Peru.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Preliminary Resource Estimates

🕔9/23/2010 12:27:08 PM 7196

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) is pleased to announce that it has completed an initial evaluation of the Lambouka-1 well results and has generated a preliminary resource estimate for the Lambouka gas discovery.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Operations Update #10

🕔9/14/2010 2:23:58 PM 7223

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) reports on activities during past week.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well - Decision To Suspend Well

🕔9/8/2010 11:35:02 AM 7045

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) is pleased to announce that the participants have agreed to the Operators proposal to suspend the Lambouka -1 discovery in a manner that is suitable for the future re-entry of the well.

Read Full Article

ADX Energy Limited (ASX:ADX) Discovers Hydrocarbon Bearing Zones in The Lambouka-1 Well

🕔9/7/2010 11:18:08 AM 8048

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) is pleased to announce hydrocarbon bearing zones have been discovered in the Lambouka-1 well. Drilling and wire line logging operations on the well have now been concluded, having reached a total measured depth of 2,786 meters.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well - Operations Update #8

🕔8/31/2010 11:24:02 AM 7786

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) reports on activities during past week.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well Interim Update 2

🕔8/30/2010 9:31:59 AM 6612

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) rig operations as at 0600 hrs Tunisian local time (GMT) on the 29th of August were at a measured depth of 2,691 m.

Read Full Article

ADX Energy Limited (ASX:ADX) Lambouka-1 Well - Interim Update

🕔8/27/2010 12:39:05 PM 7352

ADX Energy Limited (ASX:ADX) (PINK:ADXRF) rig operations as at 0600 hrs Tunisian local time on the 26th of August were drilling ahead at a measured depth of 2,511m. Since the last operations report earlier this week, the Abiod Formation limestones which are the primary target for the Lambouka well have been encountered. The Abiod intersection was associated with some losses of circulation fluids, an increase in background gas shows and an anomalously high resistivity on the Measurement While Drilling (MWD) electric logs.

Read Full Article
###

121,624 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 28) (Last 30 Days: 142) (Since Published: 19449) 

Company Data

    Headquarters
  • Suite 39, 1 Freshwater Parade
    Claremont WA 6010
    Australia
  • Telephone
  • +61 (8) 9202 6814 
  • Fax
  • +61 8 9467 6111 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 2001/10/05 
  • Homepage
  • www.pharmaust.com
  • E:
  • rogeraston@pharmaust.com

More News Results

  • 2024/03/27: Cleansing Notice*
  • 2024/03/27: Application for quotation of securities - PAA*
  • 2024/03/19: PharmAust to present at NWR Virtual Healthcare Conference*
  • 2024/03/14: Singapore Healthcare Day Presentation*
  • 2024/03/14: Positive clinical data filed with FDA to support ODD request*
  • 2024/03/07: Cleansing Notice*
  • 2024/03/07: Application for quotation of securities - PAA*
  • 2024/02/29: Appendix 4D & Half-Year Report*
  • 2024/02/28: Cleansing Notice*
  • 2024/02/28: Application for quotation of securities - PAA*
*refer to company website

Social Media